Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Orlistat in persistent type 2 diabetes after gastric banding
NCT01597531Phase 4Terminated
- Sponsor
- East Carolina University
- Start
- Jun 2012
- Primary completion
- Jun 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide, orlistat in type 2 diabetes mellitus (T2DM), sponsored by East Carolina University. Started Jun 2012; status: terminated.
02
Drugs
liraglutideorlistat
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01597531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597531.